Skip to main content
VCbacked
Log inGet Started

Cerevel Therapeutics

Boston, United States

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

$450.0M raised
Oct 2023
Post-IPO Equity
BiotechnologyPharmaceuticalTherapeutics

Top Investors

RA Capital ManagementBain CapitalPfizerAdage Capital ManagementPerceptive Advisors

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cerevel Therapeutics

How much funding has Cerevel Therapeutics raised?
Cerevel Therapeutics has raised $450.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2023.
Who are Cerevel Therapeutics's investors?
Cerevel Therapeutics's investors include RA Capital Management, Bain Capital, Pfizer, Adage Capital Management, Perceptive Advisors.
Where is Cerevel Therapeutics headquartered?
Cerevel Therapeutics is headquartered in Boston, United States.
What does Cerevel Therapeutics do?
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
What stage is Cerevel Therapeutics at?
Cerevel Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cerevel Therapeutics — Funding & Investors." VCBacked, October 11, 2023, https://www.vcbacked.co/company/cerevel-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2023). Cerevel Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/cerevel-therapeutics
Wikipedia (cite web)
{{cite web |title=Cerevel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cerevel-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K